Perspectives on therapy of cardiovascular diseases with oenzyme Q10 (Ubiquinone)
- 1 August 1993
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 71 (8) , S116-S123
- https://doi.org/10.1007/bf00226851
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathyEuropean Heart Journal, 1992
- Coenzyme Q10 content in different parts of the normal human heartClinical Physiology and Functional Imaging, 1988
- Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group.1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10.Proceedings of the National Academy of Sciences, 1985
- Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure.1985
- Micro-analysis for coenzyme Q10 in endomyocardial biopsies of cardiac patients and data on bovine and canine heartsBiochemical and Biophysical Research Communications, 1984
- Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: A biopsy studyJournal of the American College of Cardiology, 1983
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Enzymic analysis of endomyocardial biopsy specimens from patients with cardiomyopathies.Heart, 1977